A security alliance shaping the future of connected infrastructure

Tern plc

Device Authority’s KeyScaler platform has built its reputation on automating device identity at scale. Rather than relying on manual oversight, the system creates, rotates and retires digital identities across vast fleets of connected assets. For investors, the attraction is clear: this reduces exposure to breaches that often trace back to unmanaged or outdated credentials. But automation alone is only part of the equation. To be effective, these capabilities must be embedded into complex corporate ecosystems, which is where Optiv’s advisory strength comes into play.

The shift toward Zero Trust frameworks has sharpened the spotlight on machine identities. Unlike perimeter-based security, Zero Trust requires constant validation of every entity on the network. Device Authority’s identity-first approach fits directly into this narrative, while Optiv brings the experience needed to operationalise it for clients that span critical sectors such as energy, healthcare and manufacturing. The synergy points to a model where cyber defences are not bolted on as an afterthought but are woven into the operational fabric from the outset.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern notes automotive momentum at Device Authority

Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment.

Key management emerges as a delivery risk in automotive software

Key management is becoming a delivery-critical constraint in software-defined vehicles, influencing risk, compliance and programme scalability.

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals.

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Search

Search